Showing 1 - 19 results of 19 for search '(( significant ((changes decrease) OR (larger decrease)) ) OR ( significant progress decrease ))~', query time: 0.48s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Data. by Su Hwan Park (15158181)

    Published 2025
    “…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
  16. 16

    Baseline characteristics of patients. by Su Hwan Park (15158181)

    Published 2025
    “…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
  17. 17

    Study group background characteristics. by Zicheng Hu (3825313)

    Published 2024
    “…This underscores the importance of lymphocyte traffic and likely direct virus release by trafficking infected CD4+ T-cells in the determining the CSF HIV-1 levels in the neurologically asymptomatic individuals, particularly those with blood CD4+ T-cell counts above 50 cells per μL. This relationship changed markedly with the development of <b><i>HAD</i></b> and the underlying direct neuropathic parenchymal CNS infection, i.e., <b><i>HIVE</i></b>, in which the CSF HIV-1 RNA concentrations reached high levels, and the differences between it and the blood viral load decreased. …”
  18. 18

    Table 1_Efficacy of Yang Yin Sheng Xue formula against canine lymphoma chemotherapy-induced myelosuppression.docx by Wanbing Pan (22035863)

    Published 2025
    “…PI staining was performed to investigate YYSXF’s effect on cell cycle progression in the S and G2/M phases of BMCs. Histopathological changes in sternum bone marrow were examined through pathological sections. …”
  19. 19

    Table 1_A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice.docx by Yi Pan (68170)

    Published 2025
    “…In the PPC group, baseline alanine transaminase (ALT) levels decreased at 12- and 24-weeks compared to those of the control group, but results were not significant. …”